Northwestern Medicine scientists have discovered a new compound that halts the spread of multiple types of cancer cells.
Monthly Archives: May, 2018
Stuart H. Orkin, MD, an investigator of the Howard Hughes Medical Institute at Boston Children’s Hospital and Dana-Farber Cancer Institute and a professor at Harvard Medical School, is the recipient of the 2018 Mechthild Esser Nemmers Prize in Medical Science at Northwestern University.
Feinberg met its goal of raising $10 million for the newly renamed Mesulam Cognitive Neurology and Alzheimer’s Disease Center, naming the Center after its director, M. Marsel Mesulam, MD.
The second annual Center for Bioethics and Medical Humanities Conference, “Artful Medicine,” featured presentations from students, faculty, alumni and clinicians on how the arts inform medical practice and education.
On May 6, the Illinois Precision Medicine Consortium hosted a launch event at Chicago’s Millennium Park, one of many simultaneous events held around the country to mark the program’s launch.
NewCures at Northwestern University is a novel accelerator working to identify promising potential therapies in development, fund research into their viability, and promote their development as new drugs.
Mutations in a gene called DBR1 may increase patients’ susceptibility to brain infection, according to a study published in Cell.
A study, published in Proceedings of the National Academy of Sciences, provides new insights into the organization of a key protein called cadherin within structures called adherens junctions, which help cells stick together.
Scientists discovered the regulatory role of the enzyme CDK5 in an aggressive form of brain cancer and successfully halted tumor growth by inhibiting it.
Northwestern faculty members have been chosen for induction into two prominent medical organizations: the American Society for Clinical Investigation and the Association of American Physicians.